TALK

Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

Kam Dhaliwal, SVP Strategic Alliances & Dr Thomas Moreau, Head of Research. 2020. bit.bio talk at ELRIG

Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

Listen to our talk at the recent ELRIG conference and learn how bit.bio’s opti-ox™ can generate cells with high consistency and functionality at scale from human iPSCs, including those carrying disease-specific mutations, providing high-quality human models for enhanced research outcomes and drug discovery efficiency.

Download resource

    Please complete the form below.








    Please confirm that we may add you to our mailing list, and send you our latest news and updates:
    Yes, please email me

    You can unsubscribe at any time by clicking the link in the footer of our emails. Privacy policy.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms apply.

    Discover more resources

    webinars

    Webinars

    posters

    Posters

    publications

    Journals

    videos

    Videos